Ozempic Lawsuit: Everything You Need To Know About The Latest Vision Loss Allegations
If there were a “drug of the summer” award, Ozempic would win hands down. This Glucagon-Like Peptide 1 (GLP-1) receptor agonist, scientifically known as Semaglutide, was originally developed to treat type 2 diabetes. Today, it’s better known for delivering rapid, dramatic weight loss. But Ozempic’s meteoric rise has brought increased scrutiny. Its manufacturer, Novo Nordisk, […]
FDA warns Hims & Hers and other weight loss drugmakers to remove ‘false and misleading’ advertising
For the first time, federal health officials are taking aim at telehealth companies promoting unofficial versions of prescription drugs — including popular weight loss medications — as part of the Trump administration’s crackdown on pharmaceutical advertising. The Food and Drug Administration on Tuesday posted more than 100 letters to various drugmakers and online prescribing companies, including Hims & Hers, which […]
Semaglutide provides powerful protection against diabetic retinopathy, study suggests
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Pharmaceutics.
After weight loss, regular exercise rather than GLP-1 drug reduces leading cause of heart attacks and strokes
Maintaining weight loss with regular exercise rather than the glucagon-like peptide-1 receptor agonist (GLP-1RA) liraglutide, a drug used to treat type 2 diabetes and obesity, seems to reduce atherosclerosis development in adults with obesity—a leading underlying cause of cardiovascular disease.
Daily weight loss pill can help cut body weight by a fifth, trial shows
One in five people who took orforglipron once a day for 72 weeks lost 20% or more of their weight, maker Eli Lilly says A daily pill for weight loss can help people reduce their body weight by as much as a fifth, according to a trial that could pave the way for millions more […]
Semaglutide provides powerful protection against diabetic retinopathy, study suggests
GLP-1 receptor agonist drugs protect against diabetic retinopathy, a common complication of diabetes that can lead to sight loss, suggests new research being presented at the annual meeting of the European Association for the Study of Diabetes (EASD) in Vienna, Austria (15–19 September) and published in the journal Pharmaceutics.
GLP-1 receptor agonists risk becoming another story of global health inequity—what can we learn from the response to HIV/AIDS?
The arrival of glucagon-like peptide-1 receptor agonists (GLP-1 RAs) such as semaglutide and tirzepatide marks an important moment in the treatment of obesity and diabetes. Clinical trials show that these agents can deliver substantial and sustained weight loss, improve glycaemic control, and reduce cardiovascular risk.12 Yet their current annual cost—often exceeding $8000 per patient in […]
Novo Nordisk A/S (NVO): A Bull Case Theory
We came across a bullish thesis on Novo Nordisk A/S on Summit Stocks’s Substack by Summit Stocks. In this article, we will summarize the bulls’ thesis on NVO. Novo Nordisk A/S ‘s share was trading at $56.74 as of September 3rd. NVO’s trailing and forward P/E were 14.49 and 13.48 respectively according to Yahoo Finance. During […]
Gogglebox star shows off incredible 7st weight loss and looks slimmer than ever after revealing how she shed the pounds
GOGGLEBOX star Amy Tapper today showed off her incredible 7st weight loss and looked slimmer than ever. It comes just weeks after Amy, 25, revealed to The Sun her secret to shedding the pounds. Instagram/@amytappsxGogglebox star Amy Tapper showed off her slimmer than ever figure[/caption] Do The UnthinkableAmy is pictured here before her dramatic weight […]
Bank of America Reiterates Eli Lilly (LLY) Buy on GLP-1 Growth Momentum
Post Content